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Two-dimensional gel analysis of basic proteins in developing human smooth muscle identifies calponin as a prominent marker of the differentiated 
phenotype. Adult tissue (human and mouse) typically expresses up to four calponin isoforms, three of which appear sequentially during fetal 
development: adult myometrial cells express the same three isoforms in primary culture in vitro and these are down-regulated, in reverse order, 
during the subsequent modulation of phenotype. Monospccific, polyclonal antibodies against calponin identify a lower molecular weight variant 
of calponin (L-calponin) that is strongly and specifically expressed in adult smooth muscles of the human urogenital tract. L-Calponin is down- 
regulated in benign smooth muscle derived tumors (leiomyoma) and is not expressed in primary cultures of normal uterine tissue. 
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1. INTRODUCTION 
During smooth mu.scle development he major con- 
tractile proteins actin, myosin and tropomyosin show 
complex patterns of switching, from non-muscle protein 
isoforms to two or more muscle isoforms in the differen- 
tiated cell (see e.g. [l-5]). Antibodies against one or 
another actin or myosin isoform are already proving 
useful as markers of smooth muscle cells [3,4,6], but 
since these isoforms may be differentially expressed in 
different smooth muscle populations [1,4] and in cells 
other than smooth muscle [3,7,8] more markers of the 
smooth muscle phenotype are called for. Studies along 
the latter lines have already pinpointed metavinculin [9] 
and the heavy isoform of caldesmon [lo] as alternative 
and complementary markers of the smooth muscle phe- 
notype, The present study was undertaken to establish 
the possible existence of other smooth muscle specific 
proteins, emphasis being placed on analysis of the pat- 
tern of human basic proteins separated by two-dimen- 
sional gel electrophoresis under non-equilibrium condi- 
tions. The results confirm and extend more recent stud- 
ies on chick that have indicated the smooth muscle spe- 
cific expression of the protein calponin [I 11. In addition 
to showing the differential expression of calponin 
isoforms in human smooth muscle, during differentia- 
tion in vivo and phenotype modulation in vitro we de- 
scribe a new low molecular weight variant of calponin 
that is strongly expressed in smooth muscles of the 
human urogenital tract and that appears to be a late 
differentiation marker. 
2. MATERIALS AND METI-IODS 
2.1. Sample preparation 
Human smooth muscle was obtained during routine post mortem 
examination of patients within 10 hours after death from the following 
organs. Gastrointestinal: stomach, gallbladder. common bile duct, 
duodenum, jejunum, ileum, colon. Urogenital: urinary bladder, 
ureter. uterus, ductus deferens. Cardiovascular: aorta, coronary art- 
eries, carotid artery, mesenteric arteries, inferior vcna cava, portal 
vein. Pulmonary: tracheal muscle. Human fetal tissue was obtained 
during dissection of fetuses after induced interruption of pregnancy. 
The gestational ages were 12, 16,23,24,26,28 and 33 weeks as judged 
by attending gynaecological staff. 
For fetal mouse samples, pregnant &alb/c mice were sacrificed by 
cervical dislocation at day IS of gestation and adult intestines and 
myometrium as well as the fetal intestines were dissected. Intestines 
of newborn mice were also obtained in the same way. All samples werr 
snap-frozen immcdiatcly in liquid N, and stored at -7O’C. 
Samples for two-dimensional gel electrophoresis were produced 
from 6 ,um cryostat sections of the tissue blocks. to ensure fine tissue 
dispersion; the sections wcrc directly dissolved in lysis buffer [12] on 
the collecting slide. 
Cnrre.vponr/c,tce u&lress; A. Draegcr, Institute of Molecular Biology, 
Austrian Academy of Scicnccs, i3illrothstr. 11, A.5020 Salzburg, 
Austria. Fax: (43) (662) 249 6!29 
2.2. Elwrrophoresis end ittrttrtotoblorritrfi 
Non-equilibrium pH gradient clcctrophoresis (NEPHGE) was car- 
ried out according to Bravo et al. [12]. Carrier ampholines. 2.5% pH 
range 7-9; 2.5% pH range 8-10, were from &o&d. 200-300 fig of 
protein were applied to the lirst dimension and the grls run at 400 V 
for 4 h 30 min at room tcmpcraturc. The first dimension gels were 
applied to 15% slab gds lacking stacking gel and IU~ ovcrniyht at 12 
mh. Visu:!lisation of proteins was pcrformcd using the silver stain 
method according to Hcukcshovcn and Dcrnick (131, 
Blotting of gels onto nitroccllulusc sheets (Schlcichcr and Schuelt, 
Germany) Was car&d out according to Totilbin ct al. [14] and immu- 
Voluma 291, number 1 FEBS LETTERS October 1991 
Fig. 1. Non-equilibrium 2D gels (NEPHGE) of smooth muscle samples taken from the human vascular system: fourcalponin isoforms are expressed 
in human inferior vena cava (a) and three in the left anterior descending coronary artery (b). CN, calponia 
noreactions detected using the silver enhanced immunogold staining 
method, as described by Moeremans et al, [15] using a secondary 
antibody with a gold tag (Janssen Pharmaceutics, Belgium). The mo- 
noclonal antibody to desmin (LJIO) was kindly provided by Prof. M. 
Osborn; antibodies to a-smooth muscle actin, vinculin and caldesmon 
were from Sigma. The polyclonal antibody to porcine stomach calpo- 
nin (Gimona et al., in preparation) was raised in rabbits and then 
purified by affinity chromatography on porcine stomach calponin 
coupled to CNBr-activated Sepharosc 4-B (Pharmacia Fine Chemi- 
cals, Sweden). 
2.3, Tissrte cltlrrrre 
Human smooth muscle for tissue cultures was obtained from hystc- 
rectomy specimens immediately after surgery. Parallel analysis of nor- 
mal and tumorous myometrium was carried out by simultaneously 
processing each specimen for ZD-electrophoresis (see above) and tis- 
sue culture. Briefly, tissue pieces of 4-S g were chopped with a scalpel 
and vigorously stirred for 3 h at 37°C in 0.125 mg/ml collagenase I
(Sigma), 0.13 mdml hyaluronidase (Sigma) in MEM medium with 
Hank’s salts (Gibco). After filtration through a gauze layer, the cells 
were seeded into 35mm Falcon plastic dishes and cells were cultured 
in BME medium supplemented with 10% fetal calf serum, 0.1% peni- 
cillin/streptomycin and 0. I % glutamine (Gibco). Confluency was 
reached after 5 days (high seeding density) or after I2 days (moderate 
seeding density). After reaching confluency they were washed in low 
salt buffer (imidazole S mM, KCI 30 mM, MgQ, I mM, pH 7.4) and 
dissolved in lysis solution. 
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Fig. 3. Calponin expression in normal human myometrium (a,~) and ajdacent tumor tissue (leiomyoma) (b,d). a,b silver staining; c:d corresponding 
immunoblots with the calponin antibody. Calponin isoforms can be distinguished in both tissues, but I-calponin is only present in normal 
myometrium. MW, molecular weight x 10m3 
3. RESULTS antibody against porcine calponin (Fig. 2b) and could 
thus be identified as the human equivalent of this pro- 
tein. As shown in Figs. 1 and 2, three to four isoforms 
of calponin could be observed in smooth muscles of the 
vascular system (Fig. la,b) and the gastrointestinal tract 
(Fig. 2). 
3.1. Caiponin isoforms in human smooth muscles 
When two-dimensional gel patterns of basic proteins 
obtained from adult human smooth muscles were com- 
pared with a data-base accumulated from human tissues 
and cuitured cells [16] several polypeptides, apparently 
specific for smooth muscle were detected. Prominent 
among these was a group of up to 4 spots in the range 
of 34 kDa (Figs. 1 and 2a) that cross-reacted with an 
Fig, 4, Immulloblot of human urctcr smooth muscle with ralponiri 
mibndy showing prcscnce af I-calpanin. 
26 
3.2. Occurrence of I-calponin; a lower moleculur weight 
calponin vuriunt 
The analysis of uterine likewise revealed multiple iso- 
forms of calponin. A notable finding, however, was the 
presence of an additional set of polypeptides directly 
below calponin at a molecular weight of around 29 kDa 
(Fig. 3a) that cross-reacted with the calponin polyclonal 
antibody (Fig. 3~). In parallel experiments with porcine 
stomach calponin (data not shown) it could be demon- 
strated that neither deliberate nor spontaneous proteo- 
lysis of calponin gave rise to polypeptides whose posi- 
tion corresponded to those of the additional spots seen 
in uterine tissue: the latter polypeptides were therefore 
not likely products of proteolysis of 34 kDa calponin. 
Further evidence for the presence of a distinct variant 
of calponin in uterus came from parallel analysis of 
benign smooth-muscle dcrivcd t,umors (leiomyoma). In 
contrast to those from normal myometriiim the lcio. 
myoma samples howed, without exception, no dctccta- 
ble expression of the lower molecular weight calponin 
variant (Fig, 3b,d). Two variants of caldesmon of high 
and low molecular weight termed I- and h-caldcsmon 
have been described by Ueki et al. [lo]: by analogy we 
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Fig. 5. Smooth muscle specific proteins and calponin isoforms in human fetal development. (a) Immunoblots of fetal bladder (gestational age 24 
weeks), with antibodies against: caldesmon (I’), metavinculin/vinculin (2’), dcsmin (37, &smooth muscle actin (4’), and calponin (5’). All smooth 
muscle specific differentiation markers are present at this stage. b-d: 2D electrophoresis (NEPHGE) of fetal bladder at the gestational ages indicated. 
Two main isoforms were observed at 24 weeks and three from 28 weeks onwards. 
shall refer to the low molecular weight calponin variant 
as I-calponin. 
L-calponin in bladder was also expressed in bladder 
and vas deferens (not shown) as well as ureter (Fig. 4), 
suggesting that this varian,t is mainly confined to 
muscles of the urogenital tract. 
3.3. Calponin isofotww during d@erentiation and pheno- 
typic modulation of mnmmalian smooth muscle 
When we examined human fetal tissue (12-33 weeks 
of gestation) the muscle or smooth muscle specific pro- 
teins caldesmon, metavinculin, desmin, a-smooth mus- 
cle actin and calponin could be demonstrated by immu- 
noblotting (Fig. 5a): no trace of I-calponin, however, 
could be detected. At the different stages examined, 
changes in the number of calponin isoforms were also 
evident. At 12, 16 and 24 weeks only two isoforms (the 
most basic ones of those seen in adult tissue) could be 
identified in bladder (e.g. Fig. Sb). At 28 and 33 weeks 
three isoforms were apparent (Fig. %,d), as compared 
to the 4 isoforms characteristic of the adult (Figs. 1, 2 
and 3); similar data were obtained for stomach muscle. 
Intestinal smooth muscle of fetal mice at the gestatio- 
nal age 15 days showed only one calponin isoform (Fig. 
Ga), newborn mice two (Fig. 6b) and the adult intestines 
three (Fig. 6~). No I-calponin could be detected in 
mouse by immunoblotting. 
In chicks it has been shown that the modulation of 
the phenotype of gizzard cells in culture is accompanied 
by the loss of calponin expression [ 111. We confirmed 
and extended these findings with cultures of human 
myometrium. In addition, it could be shown that, apart 
from the immediate loss of I-calponin, calponin down- 
regulation occurred via a sequential oss of its isoforrns, 
starting with the most acidic (Fig. 7). This loss occurred, 
not surprisingly, in the reverse order of appearance seen 
for the same isoforms, during differentiation in vivo. 
4. DPSGUSSION 
We have identified a protein with an identical isoelee- 
tric focussing pattern (pH region 8.4 to 9.1 [17J) and a 
slightly lower molecular weight than calponin that is 
most abundant in smooth muscles of the human uroge- 
nital tract. This low molecular weight variant of calpo- 
nin may correspond to the smaller isoform described in 
a preliminary report on chick calponin cDNAs by Ta- 
kahashi et al. [18]. The appearance of phenotypically- 
specific proteins during the differentiation of smooth 
muscle is not synchronized, but temporally separated 
[19]. Whereas a-smooth muscle actin and smooth mus- 
cle specific myosin isoforms belong to the early differen- 
tiation markers [3,4], h-caldesmon and metavinculin 
appear comparatively late in fetal development [19]. 
The increase in number of calponin isoforms, up to at 
least 4 in the human adult, occurs gradually throughout 
fetal development, but I-calponin has been detected only 
Fig. 6, Calponin iroforms during dcvclogmcnt of murinc smooth muscle. Immu~~ablots with a ccrlponin antibady of samples of mouse intestine 
show scqucntitil qqxara~~rc ofcalpouin isaforms. a, IS days gestutiotl; b, newborn mouse; c, adult, 
27 
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Fig. 7. Disappearance ofcalponin isoforms during phenotype modulation in tissue culture. Primary cultures of human myometrium (a.b) showing 
the dependence of calponin isoform expression on seeding density. The y-isoform is retained up to confluency in primary cultures obtained by 
seeding ce!ls at a high density (a). Low seeding density leads to downregulation of the y-isoform at confluency (b). After the first passage the 
/?-isoform is no longer expressed (c), and the os-isoform disappears after further population doublings. 
in differentiated smooth muscle. We conclude that this 
variant may thus be a very late differentiation marker 
in the smooth muscles in which it is expressed. Not 
surprisingly, it is also the first to be down-regulated in 
tissue culture and in smooth muscle-derived tumors. 
[2] Kuro-o, M., Nagai, R.. Tsuchimochi, H., Katoh. H.. Yazaki, Y.. 
Ohkubo. A. and Takaku, F. (1989) J. Biol. Chem. 264, 1872~- 
The present of I-calponin in muscle of the urogenital 
tract raises the question as to whether it serves a specific 
function related to this system. Uterine tissue is subject 
to natural hypertrophy during pregnancy: however, the 
expression of I-calponin is apparently unrelated to this 
property. Thus, rat bladder which lacks I-calponin 
(Braeger and Malmqvist, unpublished data) does not 
exhibit synthesis of this variant after hypertrophy is 
experimentally induced [20]; the significance of l-calpo- 
nin is therefore unclear. It is however of interest to note 
that the smooth muscles of the urogenital tract derive 
from the intermediate mesoderm [21] and that this fca- 
ture may predetermine specific expression patterns. 
In conclusion, we show here the expression of calpo- 
nin isoforms during differentiation of human smooth 
muscle and the late and organ specific expression of a 
calponin variant in the urogenital tract. From recent 
studies [22,23] calponin has been attributed a regulatory 
role in the smooth muscle contractile apparatus. The 
reason for the requirement of several isoforms of this 
protein as well as a smaller variant in some tissues must 
be clarified by future work, In parallel studies (Gimona 
et al., in preparation) we have already shown, however, 
that the calponin isoforms in pig and chicken are en- 
coded by a single messenger RNA species and do not 
arise via differential phosphorylation. 
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